The adverse metabolic effects of branched-chain amino acids are mediated by isoleucine and valine
Deyang Yu,Nicole E Richardson,Cara L Green,Alexandra B Spicer,Michaela E Murphy,Victoria Flores,Cholsoon Jang,Ildiko Kasza,Maria Nikodemova,Matthew H Wakai,Jay L Tomasiewicz,Shany E Yang,Blake R Miller,Heidi H Pak,Jacqueline A Brinkman,Jennifer M Rojas,William J Quinn 3rd,Eunhae P Cheng,Elizabeth N Konon,Lexington R Haider,Megan Finke,Michelle Sonsalla,Caroline M Alexander,Joshua D Rabinowitz,Joseph A Baur,Kristen C Malecki,Dudley W Lamming
DOI: https://doi.org/10.1016/j.cmet.2021.03.025
2021-05-04
Abstract:Low-protein diets promote metabolic health in rodents and humans, and the benefits of low-protein diets are recapitulated by specifically reducing dietary levels of the three branched-chain amino acids (BCAAs), leucine, isoleucine, and valine. Here, we demonstrate that each BCAA has distinct metabolic effects. A low isoleucine diet reprograms liver and adipose metabolism, increasing hepatic insulin sensitivity and ketogenesis and increasing energy expenditure, activating the FGF21-UCP1 axis. Reducing valine induces similar but more modest metabolic effects, whereas these effects are absent with low leucine. Reducing isoleucine or valine rapidly restores metabolic health to diet-induced obese mice. Finally, we demonstrate that variation in dietary isoleucine levels helps explain body mass index differences in humans. Our results reveal isoleucine as a key regulator of metabolic health and the adverse metabolic response to dietary BCAAs and suggest reducing dietary isoleucine as a new approach to treating and preventing obesity and diabetes.